- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT05244356
Health Communication to Influence COVID-19 Vaccination Intent and Message Propagation (CONVINCE)
Effective Public Health Communication to Influence COVID-19 Vaccination Intent and Message Propagation: A Randomized Controlled Experiment
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Type d'étude
Inscription (Réel)
Phase
- N'est pas applicable
Contacts et emplacements
Lieux d'étude
-
-
Selangor
-
Shah Alam, Selangor, Malaisie, 40170
- Institute for Clinical Research, National Institutes of Health, Malaysia
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
La description
Inclusion Criteria:
- Willing and able to give informed consent for participation in the trial
- Malaysian nationality.
- Can understand either the English or Malay language.
- Aged 18 years or above
Exclusion Criteria:
- Received at least one COVID-19 vaccination dose
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Autre
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Seul
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
---|---|
Expérimental: Descriptive Norm (70%)
Intervention in the form of a message likened to a social media post. Composed of 3 parts:
|
Participants exposed to a health message and requested to read it completely.
Subsequently requested to answer post intervention questions that form basis for outcome measures.
|
Expérimental: Descriptive Norm
Intervention in the form of a message likened to a social media post. Composed of 3 parts:
|
Participants exposed to a health message and requested to read it completely.
Subsequently requested to answer post intervention questions that form basis for outcome measures.
|
Expérimental: Healthcare worker (HCW) recommendation
Intervention in the form of a message likened to a social media post. Composed of 3 parts:
|
Participants exposed to a health message and requested to read it completely.
Subsequently requested to answer post intervention questions that form basis for outcome measures.
|
Expérimental: Negative attribute framing
Intervention in the form of a message likened to a social media post. Composed of 3 parts:
|
Participants exposed to a health message and requested to read it completely.
Subsequently requested to answer post intervention questions that form basis for outcome measures.
|
Expérimental: Positive attribute framing
Intervention in the form of a message likened to a social media post. Composed of 3 parts:
|
Participants exposed to a health message and requested to read it completely.
Subsequently requested to answer post intervention questions that form basis for outcome measures.
|
Expérimental: Risky choice framing (Safety)
Intervention in the form of a message likened to a social media post. Composed of 3 parts:
|
Participants exposed to a health message and requested to read it completely.
Subsequently requested to answer post intervention questions that form basis for outcome measures.
|
Expérimental: Risky choice framing (Side effects)
Intervention in the form of a message likened to a social media post. Composed of 3 parts:
|
Participants exposed to a health message and requested to read it completely.
Subsequently requested to answer post intervention questions that form basis for outcome measures.
|
Expérimental: Control message
Control message containing only rally slogan: "It's safe and effective!"
|
Participants exposed to a health message and requested to read it completely.
Subsequently requested to answer post intervention questions that form basis for outcome measures.
|
Expérimental: Combination message: Descriptive Norm (70%) + Descriptive Norm
Participants received 2 messages which were exposed one at a time.
Sequence of message appearing randomly rotated.
|
Participants exposed to a health message and requested to read it completely.
Subsequently requested to answer post intervention questions that form basis for outcome measures.
|
Expérimental: Combination message: Descriptive Norm (70%) + HCW recommendation
Participants received 2 messages which were exposed one at a time.
Sequence of message appearing randomly rotated.
|
Participants exposed to a health message and requested to read it completely.
Subsequently requested to answer post intervention questions that form basis for outcome measures.
|
Expérimental: Combination message: Descriptive Norm (70%) + Negative attribute framing
Participants received 2 messages which were exposed one at a time.
Sequence of message appearing randomly rotated.
|
Participants exposed to a health message and requested to read it completely.
Subsequently requested to answer post intervention questions that form basis for outcome measures.
|
Expérimental: Combination message: Descriptive Norm (70%) + Positive attribute framing
Participants received 2 messages which were exposed one at a time.
Sequence of message appearing randomly rotated.
|
Participants exposed to a health message and requested to read it completely.
Subsequently requested to answer post intervention questions that form basis for outcome measures.
|
Expérimental: Combination message: Descriptive Norm (70%) + Risky choice framing (Safety)
Participants received 2 messages which were exposed one at a time.
Sequence of message appearing randomly rotated.
|
Participants exposed to a health message and requested to read it completely.
Subsequently requested to answer post intervention questions that form basis for outcome measures.
|
Expérimental: Combination message: Descriptive Norm (70%) + Risky choice framing (Side effects)
Participants received 2 messages which were exposed one at a time.
Sequence of message appearing randomly rotated.
|
Participants exposed to a health message and requested to read it completely.
Subsequently requested to answer post intervention questions that form basis for outcome measures.
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
---|---|---|
Change in intent to accept the COVID-19 vaccine amongst the Malaysian adult population.
Délai: Immediately before and after message exposure during questionnaire administration.
|
Outcome measure was assessed using a questionnaire answered through a 4 point ordinal scale.
Scale ranges from '"Definitely no", "Not sure, but probably no", "Not sure, but probably yes"to Definitely yes".
|
Immediately before and after message exposure during questionnaire administration.
|
Change in intent to recommend the COVID-19 vaccine to healthy adults.
Délai: Immediately before and after message exposure during questionnaire administration.
|
Outcome measure was assessed using a questionnaire answered through a 5 point ordinal scale.
Scale ranges from "Strongly disagree", "Disagree", "Not sure", "Agree", and "Strongly agree".
|
Immediately before and after message exposure during questionnaire administration.
|
Change in intent to recommend the COVID-19 vaccine to elderly.
Délai: Immediately before and after message exposure during questionnaire administration.
|
Outcome measure was assessed using a questionnaire answered through a 5 point ordinal scale.
Scale ranges from "Strongly disagree", "Disagree", "Not sure", "Agree", and "Strongly agree".
|
Immediately before and after message exposure during questionnaire administration.
|
Change in intent to recommend the COVID-19 vaccine to people with existing health conditions.
Délai: Immediately before and after message exposure during questionnaire administration.
|
Outcome measure was assessed using a questionnaire answered through a 5 point ordinal scale.
Scale ranges from "Strongly disagree", "Disagree", "Not sure", "Agree", and "Strongly agree".
|
Immediately before and after message exposure during questionnaire administration.
|
Intent to share message on social media platform.
Délai: Immediately after message exposure during questionnaire administration.
|
Outcome measure was assessed using a questionnaire answered through a 5 point ordinal scale.Scale ranges from "Strongly disagree", "Disagree", "Not sure", "Agree", and "Strongly agree".
|
Immediately after message exposure during questionnaire administration.
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
---|---|---|
Moderators of vaccination intent.
Délai: Immediately after message exposure during questionnaire administration.
|
Outcome measure assessed using a series of questions answered through a 5 point ordinal scale.
Scale ranges from "Strongly disagree", "Disagree", "Not sure", "Agree", and "Strongly agree".
|
Immediately after message exposure during questionnaire administration.
|
Reliability of various information sources about COVID-19.
Délai: Immediately after message exposure during questionnaire administration.
|
Outcome measure assessed using a questionnaire that list out various types of information sources and having participants to rate the reliability for each source using a 5 point ordinal scale.
Scale ranges from "Strongly not reliable", "Not reliable, "Not sure", "Reliable", and "Strongly reliable".
|
Immediately after message exposure during questionnaire administration.
|
Collaborateurs et enquêteurs
Parrainer
Collaborateurs
Les enquêteurs
- Chercheur principal: Yee Liang Hing, MSc., Clinical Research Centre, Malaysia
Publications et liens utiles
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Réel)
Achèvement primaire (Réel)
Achèvement de l'étude (Réel)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Mots clés
Termes MeSH pertinents supplémentaires
- Processus pathologiques
- Infections à Coronaviridae
- Infections à Nidovirales
- Infections par virus à ARN
- Maladies virales
- Attributs de la maladie
- COVID-19 [feminine]
- Infections à coronavirus
- Maladies pulmonaires
- Infections
- Maladies transmissibles
- Pneumonie
- Pneumonie virale
- Infections des voies respiratoires
- Troubles respiratoires
- Maladies des voies respiratoires
Autres numéros d'identification d'étude
- NMRR-21-26-58107
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .
Essais cliniques sur Infections à coronavirus
-
West Virginia UniversityInscription sur invitationInfection de la peau et des tissus mous | Infection gastro-intestinale | Infection pulmonaire | Infection des os et des articulations | Infection endovasculaire | Infection génito-urinaireÉtats-Unis
-
Taipei Medical University WanFang HospitalInconnue
-
Ondine Biomedical Inc.ComplétéInfection du site opératoire | Infection nosocomiale | Infection associée aux soins de santéÉtats-Unis
-
Croydon Health Services NHS TrustComplétéInfection du site opératoire | Infection de la plaie | Césarienne; Infection | Infection périnéaleRoyaume-Uni
-
Angela BiancoStryker NordicRésiliéCésarienne | Infection du site opératoire | Infection nosocomialeÉtats-Unis
-
Leiden University Medical CenterRadboud University Medical Center; University Medical Center Groningen; Erasmus... et autres collaborateursRecrutementInfection prothétique-articulaire | Infection de la hanche | Infection; Genou, ArticulationPays-Bas
-
Cairo UniversityRecrutementInfection postopératoire | Complications de la césarienne | Infection vaginaleEgypte
-
Gundersen Lutheran Medical FoundationGundersen Lutheran Health SystemComplétéInfection du site opératoire | Infection superficielle du site opératoire | Infection profonde du site chirurgical | Infection du site chirurgical d'un organe/de l'espaceÉtats-Unis
-
Hospices Civils de LyonRecrutement
-
Kirby InstitutePas encore de recrutementInfections fongiques invasives | Infection, bactérienne | Infection fongique | Infection au site d'injection | Infection, tissus mous | Infection bactérienne invasive
Essais cliniques sur Health message exposure
-
Florida State UniversityUniversity of North Carolina, Chapel Hill; University of GeorgiaInscription sur invitationRéduction du risque de maladies cardiovasculairesÉtats-Unis
-
IWK Health CentrePas encore de recrutement
-
Boston Children's HospitalUnited States Department of Defense; National Football LeagueComplétéCommotion cérébraleÉtats-Unis
-
Manan ShuklaComplétéAsthme | Maladie chroniqueÉtats-Unis
-
Radicle ScienceActif, ne recrute pasDouleur abdominale | Digestion | Troubles gastro-intestinauxÉtats-Unis
-
Noctrix Health, Inc.ComplétéSyndrome des jambes sans reposÉtats-Unis
-
Radicle ScienceComplétéLa dépression | La douleur | Dormir | AnxiétéÉtats-Unis
-
Medical University of GdanskPas encore de recrutementCancer de l'estomac | Cancer colorectal
-
Virginia Commonwealth UniversityAgency for Healthcare Research and Quality (AHRQ)Inscription sur invitation
-
Oxford VRCitruslabsComplétéAnxiété | Dépression, AnxiétéÉtats-Unis